Skip To Main Content
R Barron on Muck Rack

R Barron

As seen in: Value in Health Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with R

Contact R, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cost Effectiveness of Pegfilgrastim for Reducing Incidence of Febrile Neutropenia Events after Cytotoxic Chemotherapy for Solid Tumors in Turkey

|
By Amgen GmbH, G Saka, G Villa, G Worth, R Barron
| Value in Health Journal Verified
The objective of this evaluation was to assess cost-effectiveness of pegfilgrastim compared to filgrastim when used as prophylaxis in subsequent chemotherapy cycles for patients who experience a neutropenic event (NE; absolute neutrophil count <500/m3), consistent with Turkish regulatory indication. Pegfilgrastim was compared to filgrastim (5 days) for reducing incidence of FN events in patients receiving cytotoxic chemotherapy for solid tumors in Turkey.
Open in Who Shared Issue with article?
See all 1 articles